Israel Biotech Fund I, L.P.'s Net Worth
Estimate Recalculated Sep 9, 2024 12:24AM EST
Who is Israel Biotech Fund I, L.P.
Israel Biotech Fund I, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Ayala Pharmaceuticals, Inc., and Ayala Pharmaceuticals, Inc..
SEC CIK
Israel Biotech Fund I, L.P.'s CIK is 0001652458
Past Insider Trading and Trends
2020 was Israel Biotech Fund I, L.P.'s most active year for acquiring shares with 3 total transactions. Israel Biotech Fund I, L.P.'s most active month to acquire stocks was the month of April. 2020 was Israel Biotech Fund I, L.P.'s most active year for disposing of shares, totalling 2 transactions. Israel Biotech Fund I, L.P.'s most active month to dispose stocks was the month of April. 2020 saw Israel Biotech Fund I, L.P. paying a total of $3,375,000.00 for 805,988 shares, this is the most they've acquired in one year. In 2020 Israel Biotech Fund I, L.P. cashed out on 1,161,976 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
